Memesto Wearable Device for Persons With Dementia

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Alzheimer Disease
Interventions
DEVICE

Memesto

Edgewater plans to develop the next generation Memesto, a wearable device able to sense increasing agitation in ADRD sufferers and automatically deliver agitation-reducing personalized voice messages and music most effective at calming the individual based on past interventions. This innovative product will be the first wearable ADRD device to track agitation via body-worn sensors and automatically deploy agitation-reducing voice and music therapy without any caregiver interaction. The new system will use analytics to track the effectiveness of the various media and update the calming 'play list' over time.

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
collaborator

Rush University Medical Center

OTHER

lead

Edgewater Safety Systems, Inc.

INDUSTRY